Rule Allows 340B Discounts On Some Orphan Drugs

Washington Drug Letter
A A
HHS has published a final rule specifying that orphan drugs are no longer entirely excluded from cost savings under the 340B program.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00